Finance

Lists
Why is QNRX down 3.11%?
Dive Deeper
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
$ 4.36
-3.11%
(-0.14) 1D
$ 4.36
0.00% (0.00)
After hours
Closed: 10-р сарын 12, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
$ 4.83
High
$ 5.31
Low
$ 4.30
Mkt. cap
20.95 сая
Avg. vol.
1.13 сая
Volume
50.55 мян
52-wk high
$ 23.50
52-wk low
$ 3.25
EPS
-$ 423.73
Beta
1.56
Shares outstanding
4.80 сая
No. of employees
5
Open
$ 4.83
High
$ 5.31
Low
$ 4.30
Mkt. cap
20.95 сая
Avg. vol.
1.13 сая
Volume
50.55 мян
52-wk high
$ 23.50
52-wk low
$ 3.25
EPS
-$ 423.73
Beta
1.56
Shares outstanding
4.80 сая
No. of employees
5
News stories
From web sources and news partners
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current $ 4.36
$ 35.00 (+702.75%)
Average
$ 22.25 (+410.32%)
Lowest
$ 14.00 (+221.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
$ 14.00
+221.1%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
$ 20.00
+358.7%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$ 20.00
+358.7%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$ 35.00
+702.8%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
$ 12.00
+175.2%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$ 30.00
+588.1%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.28 сая
3.10 сая
3.43 сая
3.63 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74 сая
1.42 сая
1.70 сая
1.85 сая
Operating expense
4.02 сая
4.52 сая
5.13 сая
5.47 сая
Total operating expenses
4.02 сая
4.52 сая
5.13 сая
5.47 сая
Operating income
-4.02 сая
-4.52 сая
-5.13 сая
-5.47 сая
Other non operating income
9.49 мян
364.00
-13.30 мян
1.58 мян
EBT including unusual items
-3.95 сая
-4.35 сая
-5.00 сая
-5.37 сая
EBT excluding unusual items
-3.95 сая
-4.35 сая
-5.00 сая
-5.37 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.95 сая
-4.35 сая
-5.00 сая
-5.37 сая
Net profit margin
-
-
-
-
Earnings per share
-6.70
-
-1.77
-1.90
Interest and investment income
62.27 мян
171.70 мян
146.78 мян
100.95 мян
Interest expense
-
-
-
-
Net interest expenses
62.27 мян
171.70 мян
146.78 мян
100.95 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.99 сая
-4.50 сая
-5.11 сая
-5.45 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс